国家医保药品目录与其他药品目录收录眼科用药的差异分析  

Analysis on the differences of ophthalmic drugs between national medical insurance drug catalogue and other drug catalogues

作　　者：梅隆[1] 李飒[1] 张钰宣[2] 梅丹[2] 甄健存[1] MEI Long;LI Sa;ZHANG Yu-xuan;MEI Dan;ZHEN Jian-cun(Department of Pharmacy,Beijing Jishuitan Hospital,Beijing 100035,China;s 2.Department of Pharmacy,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China)

机构地区：[1]北京积水潭医院药剂科,北京100035 [2]中国医学科学院北京协和医学院北京协和医院药剂科,北京100730

出　　处：《临床药物治疗杂志》2021年第4期44-48,共5页Clinical Medication Journal

基　　金：中国医学科学院医学与健康科技创新工程(2017-12M-1-011)。

摘　　要：目的通过比对分析中国(大陆及台湾地区)、澳大利亚、英国医保目录及世界卫生组织基本药物目录中眼科用药的收录情况,为动态调整我国医保目录提供参考。方法对比我国《国家基本医疗保险、工伤保险和生育保险药品目录》(以下简称国家医保目录)、我国台湾地区《全民健康保险用药品项表》(以下简称我国台湾地区健保目录)、澳大利亚发布的药物福利计划(PBS)、《英国国家处方集》(BNF)及《世界卫生组织基本药物标准清单》(EML)中眼科用药的收录情况,并对其进行比对分析。结果5个目录共收录了143种眼科用药,其中国家医保目录收录67种,占比46.85%,我国台湾地区健保目录收录86种,PBS、BNF及EML分别收录47种、101种和16种。5个目录同时收录眼科用药7种,占比4.90%。国家医保目录包含其他目录不包含眼科用药15种,占比10.49%。国家医保目录未收录其他国家及地区目录中的眼科用药84种,占比58.74%。结论国家医保目录中的眼科用药品种与其他目录有一定差别,但对眼科的每类疾病均有涉及,可以满足临床需求。靶向制剂是所有目录中收录最多的品种,眼用复方制剂的品种还需增加。Objective This study contrasted the medicines list of ophthalmic medications in the reimbursement medicine list of China's Mainland(Mainland and Chinese Taiwan),Australia,the United Kingdom and WHO essential medicines list,Aim to provide reference for modifying the medical insurance catalogue in China.Methods Collect all the medicines used in ophthalmology department with in Chinese mainland health insurance catalogue,the pharmaceutical benefits scheme in Australia(PBS),British national formulary(BNF),Chinese Taiwan health care directory and WHO essential medicines list(EML).Comparing the similarities and differences.Results A total of 143 topical ophthalmic medicines were included in these five medicine lists.There are 67 items of medications in China's Mainland,accounting for 46.85%of the total.There are 47 items of listed in PBS,101 items in BNF,86 items of Chinese Taiwan and 16 items of WHO EML.The 5 catalogues contain 7 items at the same time,accounting for 4.90%of the total.There are 15 items are included in the national medical insurance catalogue while others are not,accounting for 10.49%of the total.84 items were not listed in,while others are,accounting for 58.74%of the total.Conclusion The ophthalmic medication of our national reimbursement medicine list has a little different from other catalogues but it almost covers each kind of ophthalmology disease.The types of drugs can meet the clinical needs.Targeted agents are the most in all catalogues,but ophthalmic compound preparations need to be increased.

关 键 词：医保药品目录 眼科用药 对比分析 

分 类 号：R95[医药卫生—药学]